Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?

C Agoni, FA Olotu, P Ramharack… - Journal of molecular …, 2020 - Springer
The drug discovery process typically involves target identification and design of suitable
drug molecules against these targets. Despite decades of experimental investigations in the …
被引用次数：68 相关文章

Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?

C Agoni, FA Olotu, P Ramharack… - Journal of Molecular …, 2020 - search.ebscohost.com
The drug discovery process typically involves target identification and design of suitable
drug molecules against these targets. Despite decades of experimental investigations in the …

[引用][C] Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?

C Agoni, FA Olotu, P Ramharack… - Journal of Molecular …, 2020 - cir.nii.ac.jp
Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools
having their say? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文 …

Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?

C Agoni, FA Olotu, P Ramharack… - Journal of Molecular …, 2020 - europepmc.org
The drug discovery process typically involves target identification and design of suitable
drug molecules against these targets. Despite decades of experimental investigations in the …

Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?

C Agoni, FA Olotu, P Ramharack… - Journal of molecular …, 2020 - pubmed.ncbi.nlm.nih.gov
The drug discovery process typically involves target identification and design of suitable
drug molecules against these targets. Despite decades of experimental investigations in the …